Company Profile

Intrinsic Therapeutics was founded in the year 2000 with the mission of offering surgeons and patients better options for treating disc herniations in the spine. Such injuries are responsible for the majority of low back pain and sciatica suffered by over 5 million people in the U.S. alone.

Currently available surgical therapies result in the further degeneration or destruction of the injured spinal level. Intrinsic's innovative procedures seek to reinforce the injured tissues, thereby restoring function and reducing the incidence of reherniation.

Intrinsic Therapeutics has built a scientific advisory board including renowned physicians and biomechanics experts from around the world to guide the development and testing of its proprietary technology. With their direction, Intrinsic's team is dedicated to increasing value for our shareholders and improving outcomes for the over 800,000 patients that undergo spine surgery each year.